PANAAMPON JUTATIP ＰａｎａａｍｐｏｎＪｕｔａｔｉｐ

… Alternative Names

Panaampon Jutatip Panaampon Jutatip

Less

Researcher Number	60868313
Affiliation (Current)	2026: 熊本大学, ヒトレトロウイルス学共同研究センター, 客員助教
Affiliation (based on the past Project Information) *help	2022 – 2024: 熊本大学, ヒトレトロウイルス学共同研究センター, 客員助教
Review Section/Research Field	Principal Investigator Basic Section 54010:Hematology and medical oncology-related
Keywords	Principal Investigator NKG2D / MICA/MICB / NK cells / Adult T cell Leukemia / NK sensitization / NK / sensitization / iMIDs / ATL

Natural Killer (NK) Cell Immunotherapy Towards Adult T Cell Leukemia (ATL) via Exaltation of MICA/B Expression and Augments NK CytotoxicityPrincipal Investigator
- Principal Investigator
  
  Panaampon Jutatip
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Early-Career Scientists
- Review Section
  
  Basic Section 54010:Hematology and medical oncology-related
- Research Institution
  Kumamoto University

All 2024 2023 2022

All Journal Article Presentation Book

[Book] Cancer Immunotherapy2024
- Author(s)
  Phoomipat Jungcharoen#, Jutatip Panaampon#, Thanit Imemkamon, Charupong Saengboonmee
- Total Pages
  48
- Publisher
  Elsevier
- Data Source
  KAKENHI-PROJECT-22K16327
[Journal Article] Interleukin-1β: Friend or foe for gastrointestinal cancers2024
- Author(s)
  Khawkhiaw Kullanat、Panaampon Jutatip、Imemkamon Thanit、Saengboonmee Charupong
- Journal Title
  
  World Journal of Gastrointestinal Oncology
  
  Volume: 16 Issue: 5 Pages: 1676-1682
- DOI
  10.4251/wjgo.v16.i5.1676
- Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16327
[Journal Article] Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanisms2024
- Author(s)
  Panaampon Jutatip、Sungwan Prin、Fujikawa Sawako、Sampattavanich Somponnat、Jirawatnotai Siwanon、Okada Seiji
- Journal Title
  
  International Immunopharmacology
  
  Volume: 138 Pages: 112612-112612
- DOI
  10.1016/j.intimp.2024.112612
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K16327
[Journal Article] Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapy2024
- Author(s)
  Jungcharoen Phoomipat、Thivakorakot Kunakorn、Thientanukij Nachayada、Kosachunhanun Natkamon、Vichapattana Chayanittha、Panaampon Jutatip、Saengboonmee Charupong
- Journal Title
  
  Exploration of Targeted Anti-tumor Therapy
  
  Volume: 5 Issue: 2 Pages: 316-331
- DOI
  10.37349/etat.2024.00220
- Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16327
[Journal Article] Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line2024
- Author(s)
  Sungwan Prin、Panaampon Jutatip、Kariya Ryusho、Kamio Satoshi、Nakagawa Rumi、Hirozane Toru、Ogura Yukiko、Abe Makoto、Hirabayashi Kaoru、Fujiwara Yukio、Kikuta Kazutaka、Okada Seiji
- Journal Title
  
  Human Cell
  
  Volume: 37 Issue: 4 Pages: 1215-1225
- DOI
  10.1007/s13577-024-01077-8
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-20K18040, KAKENHI-PROJECT-22K16327, KAKENHI-PROJECT-23K06362
[Journal Article] Establishment of Biobank and Patient-Derived Xenograft of Soft Tissue and Bone Tumors2024
- Author(s)
  Okada Seiji、Boonnate Piyanard、Panaampon Jutatip、Saisuwan Krittamate、Ogata-Aoki Hiromi、Abe Makoto、Hirabayashi Kaoru、Nakagawa Rumi、Kikuta Kazutaka
- Journal Title
  
  Cureus
  
  Volume: -
- DOI
  10.7759/cureus.74781
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K16327
[Journal Article] The promising immunotherapeutic approaches for primary effusion lymphoma2024
- Author(s)
  Jutatip Panaampon and Seiji Okada
- Journal Title
  
  Exploration of targeted anti tumor therapy
  
  Volume: X
- Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16327
[Journal Article] Dihydroartemisinin Induced Apoptosis and Synergized With Chemotherapy in Pleural Effusion Lymphoma Cells2023
- Author(s)
  PHIKULSOD PLOYPLOEN、KARIYA RYUSHO、PANAAMPON JUTATIP、OKADA SEIJI
- Journal Title
  
  Anticancer Research
  
  Volume: 43 Issue: 3 Pages: 1139-1148
- DOI
  10.21873/anticanres.16259
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K08482, KAKENHI-PROJECT-22K16327
[Journal Article] Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells2022
- Author(s)
  Panaampon Jutatip、Kariya Ryusho、Okada Seiji
- Journal Title
  
  Cancer Immunology, Immunotherapy
  
  Volume: 71 Issue: 10 Pages: 2497-2509
- DOI
  10.1007/s00262-022-03177-6
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K08482, KAKENHI-PROJECT-22K16327
[Presentation] MICA/B expression on ATL cells is crucial for NK cytotoxicity2023
- Author(s)
  Jutatip Panaampon and Seiji Okada
- Organizer
  The 8th International Conference on Cancer Research & Drug Development
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16327
[Presentation] TKM-011, Anti-CD20 Antibody Confers Multi-Properties Against Burkitt’s Lymphoma in Comparable Efficacy to Rituximab and Obinutuzumab2022
- Author(s)
  Jutatip Panaampon and Seiji Okada
- Organizer
  37th Annual Meeting of The Society for Immunotherapy of Cancer
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K16327

1. 岡田誠治

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
2. 弘實透

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

PANAAMPON JUTATIP Ｐａｎａａｍｐｏｎ Ｊｕｔａｔｉｐ

Panaampon Jutatip Panaampon Jutatip

Research Projects

Research Products

Co-Researchers

Natural Killer (NK) Cell Immunotherapy Towards Adult T Cell Leukemia (ATL) via Exaltation of MICA/B Expression and Augments NK CytotoxicityPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Book] Cancer Immunotherapy2024

Author(s)

Total Pages

Publisher

Data Source

[Journal Article] Interleukin-1β: Friend or foe for gastrointestinal cancers2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Trastuzumab, a monoclonal anti-HER2 antibody modulates cytotoxicity against cholangiocarcinoma via multiple mechanisms2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Magnetite nanoparticles: an emerging adjunctive tool for the improvement of cancer immunotherapy2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishment and characterization of TK-ALCL1: a novel NPM-ALK-positive anaplastic large-cell lymphoma cell line2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Establishment of Biobank and Patient-Derived Xenograft of Soft Tissue and Bone Tumors2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] The promising immunotherapeutic approaches for primary effusion lymphoma2024

Author(s)

Journal Title

Data Source

[Journal Article] Dihydroartemisinin Induced Apoptosis and Synergized With Chemotherapy in Pleural Effusion Lymphoma Cells2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Elotuzumab, a potential therapeutic humanized anti-SLAMF7 monoclonal antibody, enhances natural killer cell-mediated killing of primary effusion lymphoma cells2022

Author(s)

Journal Title

DOI

Data Source

[Presentation] MICA/B expression on ATL cells is crucial for NK cytotoxicity2023

Author(s)

Organizer

Data Source

[Presentation] TKM-011, Anti-CD20 Antibody Confers Multi-Properties Against Burkitt’s Lymphoma in Comparable Efficacy to Rituximab and Obinutuzumab2022

Author(s)

Organizer

Data Source

PANAAMPON JUTATIP ＰａｎａａｍｐｏｎＪｕｔａｔｉｐ